| Title: | Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis |
| Author(s): | Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA; |
| Address: | "Clinical Sciences Research Institute, University of Warwick, Coventry, Warwickshire, United Kingdom; Department of Gastroenterology, University Hospital Coventry & Warwickshire, Coventry, Warwickshire, United Kingdom. Department of Gastroenterology, University Hospital Coventry & Warwickshire, Coventry, Warwickshire, United Kingdom. School of Engineering, University of Warwick, Coventry, Warwickshire, United Kingdom. School of Engineering, University of Warwick, Coventry, Warwickshire, United Kingdom; MOAC Doctoral Training Centre, University of Warwick, Coventry, Warwickshire, United Kingdom. Department of Surgery, University Hospital Coventry and Warwickshire, Coventry, Warwickshire, United Kingdom. Clinical Sciences Research Institute, University of Warwick, Coventry, Warwickshire, United Kingdom; Department of Gastroenterology, Rotherham General Hospital, Rotherham, Yorkshire, United Kingdom" |
| DOI: | 10.1371/journal.pone.0108750 |
| ISSN/ISBN: | 1932-6203 (Electronic) 1932-6203 (Linking) |
| Abstract: | "Colorectal cancer (CRC) is a leading cause of cancer related death in Europe and the USA. There is no universally accepted effective non-invasive screening test for CRC. Guaiac based faecal occult blood (gFOB) testing has largely been superseded by Faecal Immunochemical testing (FIT), but sensitivity still remains poor. The uptake of population based FOBt testing in the UK is also low at around 50%. The detection of volatile organic compounds (VOCs) signature(s) for many cancer subtypes is receiving increasing interest using a variety of gas phase analytical instruments. One such example is FAIMS (Field Asymmetric Ion Mobility Spectrometer). FAIMS is able to identify Inflammatory Bowel disease (IBD) patients by analysing shifts in VOCs patterns in both urine and faeces. This study extends this concept to determine whether CRC patients can be identified through non-invasive analysis of urine, using FAIMS. 133 patients were recruited; 83 CRC patients and 50 healthy controls. Urine was collected at the time of CRC diagnosis and headspace analysis undertaken using a FAIMS instrument (Owlstone, Lonestar, UK). Data was processed using Fisher Discriminant Analysis (FDA) after feature extraction from the raw data. FAIMS analyses demonstrated that the VOC profiles of CRC patients were tightly clustered and could be distinguished from healthy controls. Sensitivity and specificity for CRC detection with FAIMS were 88% and 60% respectively. This study suggests that VOC signatures emanating from urine can be detected in patients with CRC using ion mobility spectroscopy technology (FAIMS) with potential as a novel screening tool" |
| Keywords: | "Adult Aged Biomarkers, Tumor/*urine Cluster Analysis Colorectal Neoplasms/*diagnosis Discriminant Analysis Female Gas Chromatography-Mass Spectrometry Humans Male *Mass Spectrometry Middle Aged Sensitivity and Specificity Volatile Organic Compounds/*urine;" |
| Notes: | "MedlineArasaradnam, Ramesh P McFarlane, Michael J Ryan-Fisher, Courtenay Westenbrink, Erik Hodges, Phoebe Thomas, Matthew G Chambers, Samantha O'Connell, Nicola Bailey, Catherine Harmston, Christopher Nwokolo, Chuka U Bardhan, Karna D Covington, James A eng Research Support, Non-U.S. Gov't 2014/10/01 PLoS One. 2014 Sep 30; 9(9):e108750. doi: 10.1371/journal.pone.0108750. eCollection 2014" |
